Viewing Study NCT01624766


Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2026-06-06 @ 6:09 PM
Study NCT ID: NCT01624766
Status: COMPLETED
Last Update Posted: 2021-02-25
First Post: 2012-06-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignant Neoplasm View
None Metastatic Malignant Neoplasm View
None Recurrent Malignant Neoplasm View
None Refractory Malignant Neoplasm View
Keywords: